NTLA - Intellia Therapeutics, Inc.

QQQ $ 472.49 $ -2.05 (-0.43 %)

DIA $ 416.26 $ -1.07 (-0.26 %)

SPY $ 562.20 $ -1.67 (-0.3 %)

TLT $ 99.62 $ -1.25 (-1.24 %)

GLD $ 235.53 $ -1.83 (-0.77 %)

Previous Close

$ 22.52

Open

$ 22.98

Bid

$ 22.49 x 100

Ask

-- x --

Day's Range

$ 22.26 - $ 23.75

52 Week Range

$ 19.21 - $ 34.94

Volume

1,723,378

Average Volume

Market Cap

2.29B

Beta (5Y Monthly)

$ 1.59

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-08-2024	06-30-2024	10-Q
2	05-09-2024	03-31-2024	10-Q
3	02-22-2024	12-31-2023	10-K
4	11-09-2023	09-30-2023	10-Q
5	08-03-2023	06-30-2023	10-Q
6	05-04-2023	03-31-2023	10-Q
7	02-23-2023	12-31-2022	10-K
8	11-03-2022	09-30-2022	10-Q
9	08-04-2022	06-30-2022	10-Q
10	05-05-2022	03-31-2022	10-Q
11	02-24-2022	12-31-2021	10-K
12	11-04-2021	09-30-2021	10-Q
13	08-05-2021	06-30-2021	10-Q
14	05-06-2021	03-31-2021	10-Q
15	02-26-2021	12-31-2020	10-K
16	11-05-2020	09-30-2020	10-Q
17	08-06-2020	06-30-2020	10-Q
18	05-07-2020	03-31-2020	10-Q
19	02-27-2020	12-31-2019	10-K
20	10-31-2019	09-30-2019	10-Q
21	08-01-2019	06-30-2019	10-Q
22	05-02-2019	03-31-2019	10-Q
23	02-27-2019	12-31-2018	10-K
24	10-31-2018	09-30-2018	10-Q
25	08-01-2018	06-30-2018	10-Q
26	05-01-2018	03-31-2018	10-Q
27	03-14-2018	12-31-2017	10-K
28	10-31-2017	09-30-2017	10-Q
29	08-01-2017	06-30-2017	10-Q
30	05-02-2017	03-31-2017	10-Q
31	03-14-2017	12-31-2016	10-K
32	11-01-2016	09-30-2016	10-Q
33	08-04-2016	06-30-2016	10-Q
34	06-03-2016	03-31-2016	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Jones Trading Initiates Coverage On Intell...
09/17/2024 20:57:27

Jones Trading analyst Debanjana Chatterjee initiates coverage on Intellia Therapeutics (NASDAQ:NTLA) with a Buy rating and a...

Reported Thursday September 12, 2024, Inte...
09/17/2024 15:31:46

First presentation of detailed Phase 2 results following previous positive topline announcement that study of NTLA-2002 met pri...

Expert Outlook: Intellia Therapeutics Thro...
09/11/2024 12:00:24

Stifel Maintains Buy on Intellia Therapeut...
09/11/2024 11:44:45

Stifel analyst Dae Gon Ha maintains Intellia Therapeutics (NASDAQ:NTLA) with a Buy and lowers the price target from $80 to $64.

Expert Ratings For Intellia Therapeutics
08/12/2024 16:01:14

JP Morgan Maintains Overweight on Intellia...
08/12/2024 14:36:44

JP Morgan analyst Brian Cheng maintains Intellia Therapeutics (NASDAQ:NTLA) with a Overweight and lowers the price target fr...

RBC Capital Maintains Outperform on Intell...
08/09/2024 19:43:27

RBC Capital analyst Luca Issi maintains Intellia Therapeutics (NASDAQ:NTLA) with a Outperform and lowers the price target fr...

Intellia Therapeutics Cash, Cash Equivalen...
08/08/2024 11:39:29

Intellia Therapeutics Q2 2024 GAAP EPS $(1...
08/08/2024 11:37:41

Intellia Therapeutics Receives UK MHRA Aut...
07/30/2024 11:41:49

Intellia Therapeutics Receives Authorizati...
07/30/2024 11:41:11

bank-of-new-york-mellon-posts-upbeat-earnings-joins-archer-aviation-rivian-automotive-and-other-big-stocks-moving-higher-on-friday

Bank of New York Mellon Posts Upbeat Earni...
07/12/2024 14:27:17

cathie-woods-ark-invest-dumps-another-325m-worth-of-tesla-shares-amid-searing-q2-deliveries-rally

Cathie Wood's Ark Invest Dumps Another $3....
07/04/2024 01:52:52

cathie-woods-ark-invest-sells-tesla-shares-worth-145m-amid-rally-driven-by-q2-delivery-numbers-picks-up-palantir-shares-again-today

Cathie Wood's Ark Invest Sells Tesla Share...
07/03/2024 02:26:04

Canaccord Genuity Maintains Buy on Intelli...
06/27/2024 13:38:05

Canaccord Genuity analyst Whitney Ijem maintains Intellia Therapeutics (NASDAQ:NTLA) with a Buy and maintains $73 price target.

cathie-woods-ark-invest-acquires-73m-worth-of-shares-in-this-promising-netflix-competitor-sells-off-coinbase-stock-amid-bitcoin-slump

Cathie Wood's Ark Invest Acquires $7.3M Wo...
06/27/2024 03:33:17

On Wednesday, Cathie Wood-led Ark Invest made significant trades in Roku Inc (NASDAQ:ROKU) and Coinbase Global Inc (NASDAQ:COIN...

Intellia Therapeutics Named Edward Dulac O...
06/26/2024 11:32:24

Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine wi...

Intellia Therapeutics Presents Data On Red...
06/25/2024 19:32:54

First-ever clinical data demonstrating redosing with an investigational in vivo CRISPR-based therapyFollow-on dosing with a 55 ...

Cantor Fitzgerald Reiterates Overweight on...
06/24/2024 18:30:10

Cantor Fitzgerald analyst Rick Bienkowski reiterates Intellia Therapeutics (NASDAQ:NTLA) with a Overweight and maintains $65...

Unveiling 6 Analyst Insights On Intellia T...
06/24/2024 18:01:29